{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:45:24Z","timestamp":1792590324182,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.yrtph.2025.105830","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T19:04:44Z","timestamp":1744398284000},"page":"105830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"S1","title":["The discovery and preclinical pharmacology of JNJ-10450232 (NTM-006), a centrally penetrant, non-opioid structural analog of acetaminophen with comparable analgesic and anti-pyretic properties but no evidence of hepatotoxicity"],"prefix":"10.1016","volume":"161","author":[{"given":"Christopher M.","family":"Flores","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen E.","family":"Codd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Dax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin K.","family":"Kuffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Stahle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Neff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary E.","family":"Eichenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2025.105830_bib1","doi-asserted-by":"crossref","first-page":"11165","DOI":"10.1073\/pnas.0404185101","article-title":"Acetaminophen-induced hypothermia in mice is mediated by a prostaglandin endoperoxide synthase 1 gene-derived protein.Proc","volume":"101","author":"Ayoub","year":"2004","journal-title":"Natl. Acad. Sci. U. S. A."},{"issue":"5329","key":"10.1016\/j.yrtph.2025.105830_bib2","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.277.5329.1094","article-title":"Functional role of high-affinity anandamide transport, as revealed by selective inhibition","volume":"277","author":"Beltramo","year":"1997","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.yrtph.2025.105830_bib3","doi-asserted-by":"crossref","first-page":"13926","DOI":"10.1073\/pnas.162468699","article-title":"COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic\/antipyretic drugs: closing, structure, and expression","volume":"99","author":"Chandrasekharan","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1\u20132","key":"10.1016\/j.yrtph.2025.105830_bib4","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejphar.2007.07.012","article-title":"The local antinociceptive effects of paracetamol in neuropathic pain are mediated by cannabinoid receptors","volume":"573","author":"Dani","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105830_bib5","first-page":"411","article-title":"Acetaminophen-induced hypothermia, an AIDS related side-effect? About 4 cases","volume":"153","author":"Denes","year":"2002","journal-title":"Ann. Med. Int. (Paris)"},{"key":"10.1016\/j.yrtph.2025.105830_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0165-2478(02)00268-7","article-title":"COX-3: in the wrong frame of mind","volume":"86","author":"Dinchuk","year":"2003","journal-title":"Imm. Lett."},{"key":"10.1016\/j.yrtph.2025.105830_bib7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2261-3-2","volume":"3","author":"Dippel","year":"2003","journal-title":"BMC Cardiovasc. Dis."},{"issue":"11","key":"10.1016\/j.yrtph.2025.105830_bib8","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s40261-017-0560-x","article-title":"Acetaminophen (paracetamol) induces hypothermia during acute cold stress","volume":"37","author":"Foster","year":"2017","journal-title":"Clin. Drug Invest."},{"issue":"12","key":"10.1016\/j.yrtph.2025.105830_bib9","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.2042-7158.1973.tb09987.x","article-title":"The binding of paracetamol to plasma proteins of man and pig","volume":"25","author":"Gazzard","year":"1973","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105830_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2022.105236","article-title":"First-in-human study to evaluate the safety, tolerability and pharmacokinetics of a novel analgesic and antipyretic drug with structural similarity to acetaminophen","volume":"134","author":"Gelotte","year":"2022","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105830_bib11","article-title":"JNJ-10450232 (NTM-006), A novel non-opioid with structural similarities to acetaminophen, produces relatively long-lasting analgesia after a single dose in patients undergoing 3rd molar extraction","author":"Gelotte","year":"2023","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105830_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(95)00302-2","article-title":"Etodolac selectively inhibits human prostaglandin G\/H synthase 2 (PGHS-2) versus human PGHS-1","volume":"281","author":"Glaser","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105830_bib13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10787-013-0172-x","article-title":"The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, toxicity and recent pharmacological findings","volume":"21","author":"Graham","year":"2013","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.yrtph.2025.105830_bib14","doi-asserted-by":"crossref","first-page":"31405","DOI":"10.1074\/jbc.M501489200","article-title":"Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system","volume":"280","author":"H\u00f6gest\u00e4tt","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yrtph.2025.105830_bib15","unstructured":"International Association for the Study of Pain. IASP Guidelines for the Use of Animals in Research. https:\/\/www.iasp-pain.org\/resources\/guidelines\/iasp-guidelines-for-the-use-of-animals-in-research\/, Washington, DC. Accessed 22Jun2024."},{"key":"10.1016\/j.yrtph.2025.105830_bib16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/hs0102.101477","article-title":"Acetaminophen for altering body temperature in acute stroke: a randomized clinical trial","volume":"33","author":"Kassner","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.yrtph.2025.105830_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.prostaglandins.2007.10.007","article-title":"Acetaminophen: antipyretic or hypothermic in mice? In either case, PGHS-1b (COX-3) is irrelevant","volume":"85","author":"Li","year":"2008","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.yrtph.2025.105830_bib18","article-title":"Metabolism and disposition of JNJ-10450232 (NTM-006) in rats, dogs, monkeys and humans","author":"Lim","year":"2023","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.yrtph.2025.105830_bib19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pain.2008.03.030","article-title":"Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia","volume":"139","author":"Mallet","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.yrtph.2025.105830_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0300-483X(82)90029-4","article-title":"Acetaminophen-induced hypothermia in mice: evidence for a central action of the parent compound","volume":"25","author":"Massey","year":"1982","journal-title":"Toxicology"},{"issue":"10","key":"10.1016\/j.yrtph.2025.105830_bib21","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1096\/fj.201800272R","article-title":"The antipyretic effect of paracetamol occurs independent of transient receptor potential ankyrin 1-mediated hypothermia and is associated with prostaglandin inhibition in the brain","volume":"32","author":"Mirrasekhian","year":"2018","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.yrtph.2025.105830_bib22","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/000456329403100512","article-title":"Studies on paracetamol binding to serum proteins","volume":"31","author":"Milligan","year":"1994","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.yrtph.2025.105830_bib23","series-title":"Guide for the Care and Use of Laboratory Animals","year":"2011"},{"issue":"1\u20133","key":"10.1016\/j.yrtph.2025.105830_bib24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejphar.2005.12.015","article-title":"The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors","volume":"531","author":"Ottani","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.yrtph.2025.105830_bib25","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1124\/jpet.105.090944","article-title":"Cloning, expression and functional characterization of human cyclooxygenase-1 splicing variants: evidence for intron 1 retention","volume":"315","author":"Qin","year":"2005","journal-title":"J Pharmacol. Experimental Ther."},{"key":"10.1016\/j.yrtph.2025.105830_bib26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neuropharm.2013.03.012","article-title":"Acetaminophen reduces lipopolysaccharide-induced fever by inhibiting cyclooxygenase-2","volume":"71","author":"Ruud","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.yrtph.2025.105830_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(03)12841-3","article-title":"COX-3: just another COX or the solitary elusive target of acetaminophen?","author":"Schwab","year":"2003","journal-title":"Lancet 361981\u2013361982"},{"issue":"24","key":"10.1016\/j.yrtph.2025.105830_bib28","doi-asserted-by":"crossref","first-page":"7800","DOI":"10.1021\/jm800807k","article-title":"New analgesics synthetically derived from the paracetamol metabolite N-(4-hydroxyphenyl)-(5Z,8Z,11Z,14Z)-icosatetra-5,8,11,14-enamide","volume":"51","author":"Sinning","year":"2008","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.yrtph.2025.105830_bib29","first-page":"153","article-title":"Paracetamol: mechanisms and updates","volume":"14","author":"Sharma","year":"2014","journal-title":"Cont. Educ. Anaesth. Crit. Care Pain"},{"key":"10.1016\/j.yrtph.2025.105830_bib30","first-page":"57","article-title":"Hypothermia: an unusual side effect of paracetamol","volume":"31","author":"Van Tittelboom","year":"1989","journal-title":"Vet. Hum. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105830_bib31","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0041-008X(81)90303-3","article-title":"Acetaminophen-induced hypothermia, hepatic congestion and modification by N-acetylcysteine in mice","volume":"59","author":"Walker","year":"1981","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105830_bib32","article-title":"Preclinical safety assessment of JNJ-10450232 (NTM-006), a structural analog of acetaminophen, that does not cause hepatotoxicity at supratherapeutic doses","author":"Zhou","year":"2023","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.yrtph.2025.105830_bib33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(00)00207-7","article-title":"The anandamide transport inhibitor AM404 activates vanilloid receptors","volume":"396","author":"Zygmunt","year":"2000","journal-title":"Eur J Pharmcol"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230025000601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230025000601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T20:15:51Z","timestamp":1768853751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230025000601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":33,"alternative-id":["S0273230025000601"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2025.105830","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The discovery and preclinical pharmacology of JNJ-10450232 (NTM-006), a centrally penetrant, non-opioid structural analog of acetaminophen with comparable analgesic and anti-pyretic properties but no evidence of hepatotoxicity","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2025.105830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105830"}}